Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Molecular Informatics|July 28, 2026
To What Extent Can We Extrapolate Proteochemometric Models: A Case Study for the SLC6 Transporter FamilyUday Abu-Shehab, Gerhard EckerCurrent Opinion in Investigational Drugs (London, England : 2000)|November 15, 2002
Troxacitabine (Shire Pharmaceuticals)Gerhard EckerArchiv Der Pharmazie|January 16, 2026
A Proteochemometric Model for Ligands of the SLC5 Transporter FamilyMartin Juhás, Gerhard EckerJournal of Chemical Information and Computer Sciences|January 27, 2004
Topological distance based 3D descriptors for use in QSAR and diversity analysisChristian T Klein, Dominik Kaiser, Gerhard EckerJournal of Computer-Aided Molecular Design|November 26, 2003
MCASE study of the multidrug resistance reversal activity of propafenone analogsGilles Klopman, Hao Zhu, Gerhard Ecker, et al.Future Medicinal Chemistry|June 26, 2014
'Big data' in pharmaceutical science: challenges and opportunitiesAl G Dossetter, Gerhard Ecker, Hugh Laverty, et al.Journal of Chemical Information and Modeling|May 14, 2014
Applicability Domain ANalysis (ADAN): a robust method for assessing the reliability of drug property predictionsPau Carrió, Marta Pinto, Gerhard Ecker, et al.International Journal of Antimicrobial Agents|September 19, 2003
Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeastManuela Schuetzer-Muehlbauer, Birgit Willinger, Ralf Egner, et al.Journal of Chemical Information and Computer Sciences|September 28, 2004
Insights into phenylalanine derivatives recognition of VLA-4 integrin: from a pharmacophoric study to 3D-QSAR and molecular docking analysesAntonio Macchiarulo, Gabriele Costantino, Mirco Meniconi, et al.Bioorganic & Medicinal Chemistry|October 7, 2004
Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationshipMarek Murias, Norbert Handler, Thomas Erker, et al.Pageof 2